Record nummer 2246123
Titel artikel Development of a common priority list of pharmaceuticals relevant for the water cycle
Auteur(s) Voogt, P. de ; Janex-Habibi, M.L. ; Sacher, F. ; Puijker, L. ; Mons, M.
Tijdschrifttitel Water science and technology : a journal of the International Association on Water Pollution Research
Deel(Jaar)Nummer 59(2009)1
Paginering 39 - 46
Online full text
Op papier Haal het document, vind aanverwante informatie of gebruik andere SFX-diensten
Publicatie type Artikel
Taal Engels
Toelichting (Engels) Pharmaceutically active compounds (PhACs), including prescription drugs, over-the-counter medications, drugs used in hospitals and veterinary drugs, have been found throughout the water cycle. A desk study was initiated by the Global Water Research Coalition to consolidate a uniform selection of such compounds in order to judge risks of PhACs for the water cycle. By identifying major existing prioritization efforts and evaluating the criteria they use, this study yields a representative and qualitative profile (‘umbrella view’) of priority pharmaceuticals based on an extensive set of criteria. This can then be used for further studies on analytical methods, occurrence, treatability and potential risks associated with exposure to PhACs in water supply, identifying compounds most likely to be encountered and that may have significant impact on human health. For practical reasons, the present study excludes veterinary drugs. The pragmatic approach adopted provides an efficient tool to manage risks related to pharmaceuticals and provides assistance for selecting compounds for future studies.
Betrokken instanties KWR, Watercycle Research Institute
Er zijn nog geen reacties. U kunt de eerste schrijven!
Schrijf een reactie

To support researchers to publish their research Open Access, deals have been negotiated with various publishers. Depending on the deal, a discount is provided for the author on the Article Processing Charges that need to be paid by the author to publish an article Open Access. A discount of 100% means that (after approval) the author does not have to pay Article Processing Charges.

For the approval of an Open Access deal for an article, the corresponding author of this article must be affiliated with Wageningen University & Research.